Transplantation Characteristics
| Conditioning | |
| BuCy | 35 |
| BuCy + other | 3 |
| Cy/TBI | 12 |
| Cy/TBI + other | 10 |
| Stem cell source | |
| Related donor | 38 |
| Unrelated donor | 22 |
| GVHD prophylaxis | |
| CSP/MTX | 33 |
| CSP/MTX + other | 9 |
| CSP/TCD | 10 |
| CSP/MP | 7 |
| MTX/MP | 1 |
| Conditioning | |
| BuCy | 35 |
| BuCy + other | 3 |
| Cy/TBI | 12 |
| Cy/TBI + other | 10 |
| Stem cell source | |
| Related donor | 38 |
| Unrelated donor | 22 |
| GVHD prophylaxis | |
| CSP/MTX | 33 |
| CSP/MTX + other | 9 |
| CSP/TCD | 10 |
| CSP/MP | 7 |
| MTX/MP | 1 |
Abbreviations: Bu, busulfan; Cy, cyclophosphamide; TBI, total body irradiation; GVHD, graft-versus-host disease; CSP, cyclosporine; MTX, methotrexate; TCD, T-cell depleted bone marrow; MP, methylprednisolone.